The largest database of trusted experimental protocols

7 protocols using nordihydroguaiaretic acid ndga

1

Arachidonic Acid Metabolism in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 and MCF-7 cells were cultured in RPMI-1640 and DMEM/Ham’s F-12 (Gibco Invitrogen, Carlsbad, CA) media, respectively. Both RPMI and DMEM were supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 1% penicillin/streptomycin (Hyclone, Logan, UT). Breast cancer cells were grown in a humidified atmosphere (95% air and 5% CO2) until they reached ~80%–90% confluency. Confluent cells were treated with trypsin (0.25% Trypsin-EDTA, Hyclone), harvested by centrifugation, plated on a 6-well plate (~0.5 × 106 cells per well), and treated with AA (sodium salt, 100 μM) (Sigma Chemicals, St. Louis) for 24 h with and without prior treatment with the 5-LOX inhibitor, nordihydroguaiaretic acid (NDGA, 5 μM; Sigma Chemicals), and zileuton (100 μM; Sigma Chemicals). Control and treated cells were collected, washed, and subject to further analyses as described in the text.
+ Open protocol
+ Expand
2

Glucose Transport Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

d‐glucose, sodium bisulfite, sodium phosphate dibasic anhydrous, sodium chloride, potassium chloride, magnesium chloride, potassium phosphate monobasic, sodium dodecyl sulfate (SDS), HEPES, dimethylsulfoxide, dithiothreitiol, and TRIS‐base were obtained from JT Baker. Cytochalasin B, cytochalasin E, d‐sorbitol, 2‐deoxy‐d‐glucose (2DG), 3‐O‐methyl‐d‐glucose (OMG), and nordihydroguaiaretic acid (NDGA) were obtained from Sigma Chemical Co, St. Louis, MO, USA. All radioisotopes (2‐[1,2‐3H(N)]‐deoxy‐d‐glucose, 36.2 Ci mmol−1; 3‐O‐[methyl‐3H]‐methyl‐d‐glucose, 86.7 Ci mmol−1; [4‐3H(N)]‐Cytochalasin B, 20 Ci mmol−1) were from American Radiolabeled Chemicals, St. Louis, MO, USA. Trypan Blue, HyClone RPMI 1640 cell culture media and FBS were from Thermo Fisher Inc., Waltham, MA, USA.
+ Open protocol
+ Expand
3

Regulation of hUCB-MSCs by Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
hUCB-MSCs were obtained from MEDIPOST Co. Ltd (Seoul, Korea). Fetal bovine serum was bought from BioWhittaker Inc. (Walkersville, MO, USA). AA, A23187, bisindolylmaleimide I, BrdU, Indomethacin, LY294002, mitomycin C, Nordihydroguaiaretic acid (NDGA), rapamycin, 1-Aminobenzotriazole (1-ABT), and SB203580 were aquired from the Sigma Chemical Company (St Louis, MO, USA). Phospho-Aktser473, phospho-Aktthr308, Akt1/2/3, β-Actin, collagen1A, collagen3A, collagen5A, fibronectin, phospho-p38, p38, phospho-JNK, JNK, p-ERK1/2, ERK, lamin A/C, MMP-12, pan-cadherin, PKCα, PKCɛ, PKCθ, PKCζ, PKC, Phospho-PKCζ, and Sp1 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Phospho-PKC, phospho-mTORser2481 (mTORC2), phospho-mTORser2448 (mTORC1), and mTOR were purchased from Cell Signaling (Beverly, MA, USA). The Akt inhibitor I was aquired from Calbiochem (La Jolla, CA, USA). The CD34, GPR40, phospho-Sp1, and MT3-MMP antibodies were obtained from Abcam (Cambridge, MA, USA). Mithramycin A was purchased from Tocris (Bristol, UK). Zymogram gels were bought from Novex (San Diego, CA, USA). Horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit IgG were obtained from Jackson Immunoresearch (West Grove, PA, USA). All other reagents were used as received and were of the highest purity commercially available.
+ Open protocol
+ Expand
4

Vascular Smooth Muscle Contractility Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The composition of PSS (in mM) was 119 NaCl, 4.7 KCl, 1.2 KH2PO4, 25 NaHCO3, 1.2 MgSO4, 11.1 glucose, and 1.6 CaCl2. The composition of 60 mM KCl solution (in mM) was 59 NaCl, 60 KCl, 1.2 KH2PO4, 25 NaHCO3, 1.2 MgSO4, 11.1 glucose, and 1.6 CaCl2. All salts were purchased from Sigma Aldrich (Schnelldorf, Germany). XE991 was purchased from Tocris (Bristol, UK). 5-HT, phenylephrine (PE), 4-aminopyridine (4-AP), nordihydroguaiaretic acid (NDGA), 17-octadecynoic acid (ODYA), 12-(3-adamantan-1-ylureido)-dodecanoic acid (AUDA) were purchased from Sigma Aldrich (Schnelldorf, Germany). PAME were purchased from Cayman Chemical (Ann Arbor, Michigan, USA).
Data were analyzed by Prism version 5.0 (GraphPad Software, La Jolla, California, USA) and were shown as mean ± SD or mean ± SEM. Paired, unpaired Student's t-tests or one-way ANOVA were used as appropriate. In Figures 1C, 2C, statistical significance was determined by two-way ANOVA or repeated-measures two-way ANOVA, followed by Bonferroni post-hoc test, and using Prism 6 software. A value of P < 0.05 was considered statistically significant; n represents the number of arteries tested.
+ Open protocol
+ Expand
5

In Vitro Soybean LOX Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro inhibition of soybean LOX was followed the previously described method8 (link). The tested compounds were dissolved in DMSO as 10 mM stock solutions. 10 μL were incubated at room temperature with sodium linoleate (100 mM) and 0.2 mL of enzyme solution (1/9 × 10−4 w/v in saline) in buffer pH 9 (tris) at room temperature (final volume 1 mL). The conversion of sodium linoleate to 13-hydroperoxylinoleic acid at 234 nm was recorded. The results were compared with the appropriate standard inhibitor NDGA (IC50 = 0.45 μM). Several concentrations were used for the determination of IC50 values. The results are given in Table 1 expressed as IC50 values or % inhibition at 100 μM and compared with the appropriate standard inhibitor. Nordihydroguaiaretic acid (NDGA) (Aldrich Chemical Co. Milwaukee, WI, (USA), was used as a positive control. To determine the IC50 values, several dilutions of compounds were used. Blank determination served as a negative control.
+ Open protocol
+ Expand
6

Antioxidant and Anti-inflammatory Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Several assays were used to evaluate in vitro antioxidant activity of nitrones, such as the inhibition of lipid peroxidation (LP), induced by AAPH in the presence of atmospheric oxygen, competition of the tested compounds with DMSO, in terms of hydroxyl radical scavenging activity, and ABTS+∙ decolorization assay. In vitro inhibition of soybean lipoxygenase (LOX) was used to determine anti-inflammatory activity. Reagents and materials: nordihydroguaiaretic acid (NDGA), Trolox, 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH), soybean LOX, and linoleic acid sodium salt were from Aldrich Chemical Co. Milwaukee, WI, (USA). Phosphate buffer (0.1 M, pH 7.4) was prepared by mixing an aqueous KH2PO4 solution (50 mL, 0.2 M), and an aqueous NaOH solution (78 mL, 0.1 M); pH (7.4) was adjusted by adding a solution of KH2PO4 or NaOH. A Lambda 20 (Perkin–Elmer-PharmaSpec 1700, Boston, MA, USA) UV–Vis double beam spectrophotometer was used for the assays.
+ Open protocol
+ Expand
7

Investigating NF-κB Signaling Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NF-κB inhibitors used include: Compound A (gift from Bayer), IKK inhibitor VII (Calbiochem), IKK2 inhibitor IV (Calbiochem), Wedelolactone (Calbiochem), and MG-132 (Calbiochem). Caspase activation was inhibited by zVAD-fmk (Calbiochem). ROS production and apoptosis was inhibited by butylated hydroxyanisole (BHA) (Sigma), deferoxamine (DFO) (Calbiochem) and nordihydroguaiaretic acid (NDGA) (Aldrich). The NADPH oxidase inhibitors diphenylene iodine (DPI) and apocynin were obtained from Sigma. All compounds were diluted as suggested by manufacturers in DMSO and then diluted in desired media. MTT (Sigma) was diluted to 5 mg/ml in Opti-mem media (Invitrogen). Etanercept was obtained from Wyeth Pharmaceuticals. The JNKI/II inhibitor, SP600125, was obtained from Sigma. NF-κB activators were obtained as follows TNFα (Ebioscience), LPS (Sigma), CpG (Invitrogen), IL-1β (Peprotech).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!